Timing clarification: Welltower is scheduled to release Q2 results after the market closes today, Monday, July 27, 2026. The earnings call is tomorrow, Tuesday, July 28, at 9:00 a.m. ET. (welltower.com)
Welltower enters Q2 with exceptionally strong operating momentum—and an exceptionally demanding valuation.
The core senior-housing business continues to benefit from occupancy recovery, pricing power, limited new supply and operating leverage. Meanwhile, Welltower’s strong balance sheet and cost of capital have allowed it to acquire assets at a pace few competitors can match.
But much of that strength is now reflected in the stock. WELL closed around $252.50 on July 24, up roughly 36% year to date, and trades at approximately 40x the midpoint of management’s 2026 normalized FFO guidance. Consequently, merely meeting estimates may not be enough: investors are likely looking for another guidance increase, continued 20%-type senior-housing NOI growth and evidence that recent acquisitions can extend—not dilute—the company’s per-share growth trajectory. (marketbeat.com)
| Metric | Q2 2026 expectation | Q2 2025 actual | Implied growth |
|---|---|---|---|
| Normalized FFO per share | $1.55 | $1.28 | ~21% |
| Revenue | $3.43 billion | $2.55 billion | ~35% |
| GAAP EPS | Approximately $0.64 | $0.45 | Less useful due to real-estate gains and depreciation |
The normalized FFO estimate has increased by approximately $0.01 over the past month. Welltower has beaten normalized FFO expectations in each of the past four quarters, with an average surprise of about 2.5%. (zacks.com)
For this REIT, normalized FFO, same-store NOI and operating metrics matter more than GAAP EPS.
In Q1, Welltower delivered:
SHO represented roughly 74% of same-store NOI, making its performance the overwhelming driver of the consolidated growth rate. (welltower.com)
Occupancy: Management’s full-year outlook assumes approximately 350 basis points of year-over-year occupancy growth. Q2 includes an important portion of the peak leasing season, so investors will want evidence that occupancy momentum remains around or above that level.
RevPOR: The full-year assumption is 5% growth. Results near 5% would confirm that Welltower can retain pricing power while leasing up the portfolio. A material deceleration would raise questions about whether occupancy is being bought through lower pricing.
ExpPOR and labor: Q1’s 0.4% ExpPOR increase was unusually low. Management’s full-year guidance implies ExpPOR growth below 1.5%. This is arguably the most important operating number after occupancy: modest unit-cost growth allows incremental revenue to flow through at very high margins.
Margins: Q1 SHO margins expanded 320 basis points. Continued expansion around 300 basis points would support management’s argument that the recovery has years left to run, even as occupancy approaches prior peaks.
A particularly strong combination would be:
The last point matters because extremely low labor-cost growth may not be indefinitely repeatable.
After Q1, Welltower raised 2026 normalized FFO guidance from $6.09–$6.25 to $6.21–$6.35, lifting the midpoint by $0.11 to $6.28. It also raised the midpoint of SHO same-store NOI guidance to 19%. (welltower.com)
Current full-year operating guidance is:
| Segment | 2026 same-store NOI growth |
|---|---|
| Seniors Housing Operating | 16.5%–21.5% |
| Seniors Housing Triple-Net | 3.0%–4.0% |
| Outpatient Medical | 2.0%–3.0% |
| Long-Term/Post-Acute Care | 2.0%–3.0% |
| Total portfolio | 12.25%–16.0% |
Given the stock’s appreciation and Q1’s above-plan performance, investors are likely pricing in another increase.
The quality of the guidance increase matters. A raise driven by same-store operations and per-share acquisition accretion would be more valuable than one driven mainly by transaction timing, taxes or normalizing items.
At the Q1 report, Welltower had completed or committed to approximately $10.5 billion of 2026 investment activity, including $3.3 billion completed in Q1 and $7.2 billion closed or under contract after quarter-end. The largest item was the April 1 acquisition of 38 Amica senior-housing communities in Canada for a pro-rata purchase price of approximately C$4.1 billion. (welltower.com)
The key questions are now:
The Amica assets and other recent acquisitions will initially increase reported revenue and NOI but generally remain outside the same-store pool until they satisfy Welltower’s seasoning requirements. Investors should therefore distinguish between:
A large gross investment number is not inherently bullish if it requires excessive equity issuance or fails to improve FFO per share.
Welltower ended Q1 with:
It also repaid $700 million of notes in April using free cash flow. (welltower.com)
In July, Welltower issued C$1.15 billion of Canadian-dollar unsecured debt: C$750 million of 3.85% notes due 2031 and C$400 million of 4.15% notes due 2033. The financing provides attractive local-currency funding for Canadian investments and further demonstrates the company’s access to capital. (sec.gov)
A stable leverage outlook despite billions of dollars of acquisitions would be a meaningful positive.
In June, Welltower announced a 15% increase in the quarterly dividend to $0.85 per share, beginning with Q2. Management cited its low payout ratio, balance-sheet strength and confidence in future cash-flow growth. (welltower.com)
The annualized dividend is now $3.40 per share, but at the recent stock price the yield is only about 1.35%. Investors are therefore not buying WELL primarily for current income. The valuation depends on sustained double-digit FFO growth and continued multiple support.
Watch for the Q2 normalized FFO payout ratio and management’s commentary on future dividend growth.
Welltower has begun building fee-generating businesses around:
Management has said interest in the data-science platform has been strong, but it has not yet provided a meaningful medium-term earnings target. Q2 commentary could help investors assess whether this is becoming a real source of recurring revenue or remains strategic optionality.
The most useful disclosures would be:
Investors should avoid assigning a large valuation to this business until revenue and economics become measurable.
At roughly 40x the midpoint of 2026 normalized FFO guidance, expectations are extremely high. A conventional beat-and-maintain quarter could still produce a negative share-price reaction.
Q1’s 0.4% ExpPOR growth may prove difficult to repeat. Higher wages, insurance, utilities or food costs could narrow the gap between RevPOR and ExpPOR.
Welltower’s portfolio expanded rapidly. Execution across thousands of properties, numerous operators and multiple countries is now as important as transaction sourcing.
Welltower has generally funded investments conservatively, but equity issuance can limit FFO-per-share accretion even when absolute NOI and EBITDA rise sharply.
The company’s premium valuation provides a powerful cost-of-capital advantage, but it also increases the temptation to prioritize transaction volume. Investors should focus on expected unlevered returns and per-share value creation.
The Canadian and U.K. portfolios create foreign-exchange exposure, while higher debt balances may cause interest expense to grow faster than expected.
| Metric | Bullish interpretation | Potential concern |
|---|---|---|
| Normalized FFO/share | Above $1.55 | Below $1.55 |
| Revenue | Above roughly $3.43B | Growth materially below expectations |
| SHO same-store NOI | 20%+ | Below revised full-year trajectory |
| Occupancy growth | Around or above 350 bps | Material deceleration |
| RevPOR | Approximately 5% or better | Weakening pricing |
| ExpPOR | Below roughly 1.5% | Labor or operating-cost reacceleration |
| SHO margin | Continued major expansion | Flow-through declines |
| 2026 FFO guidance | Midpoint raised above $6.28 | Maintain or cut |
| Leverage | Near 3x despite acquisitions | Unexpected increase |
| Investment pipeline | Closings on plan; returns intact | Delays, repricing or dilution |
| Capital-light businesses | New customers or quantifiable revenue | Continued narrative without numbers |
The operating setup remains favorable. Senior-housing demand is strong, supply is constrained, Welltower still has substantial occupancy and margin-recovery potential, and its balance sheet gives it an unusual ability to acquire assets during volatile capital markets.
The complication is price. At approximately 40x current-year normalized FFO guidance, investors are already paying for years of exceptional execution. The most important outcome is therefore not whether Welltower beats Q2 FFO by a few cents. It is whether management can demonstrate that:
A strong beat plus higher guidance and stable leverage would reinforce the premium valuation. A beat without an outlook increase may be insufficient after the stock’s substantial run.